Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Knowing when to consider gold as an asset is essential for maximizing investment returns. Learn the best timing strategies now.
20,242 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Tokenized equities on-chain may alter how investors diversify. As banks test cross-rail settlement, the case for broa...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
A Ramsey Show caller with a $1.3M equity stake in a three‑unit property chooses an unconventional path: move aboard h...
The Senate Banking Committee advanced the Digital Asset Clarity Act on May 14, 2026, triggering an immediate rally in...
A Texas Democratic runoff produced a pro-crypto victory over longtime incumbent Al Green, backed by Fairshake and a w...
A century-and-a-half-old Indiana company is drawing fresh investor attention with a plan to become the world's larges...
A fresh wave of GPU backed lending is swelling to a multi-billion market, prompting comparisons to pre-2008 mortgage ...
Europe’s mica regime is now fully in force, bringing a unified licensing framework to the EU. The move reshapes who w...
Fundstrat co-founder Tom Lee points to the ETH/BTC ratio as a sign of a potential leadership shift in crypto, suggest...
Starboard Value is pressing Riot Platforms to accelerate its pivot into AI data centers, arguing Texas power assets c...
Federal regulators are moving to expand Fed master account access for crypto firms, a shift TD Cowen says banks canno...